NEW YORK, Dec. 12, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Match Group, Inc. (NASDAQ: MTCH). Shareholders who purchased shares of MTCH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff…
Tag: PR Newswire
NEW YORK, Dec. 12, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Chipotle Mexican Grill, Inc. (NYSE: CMG). Shareholders who purchased shares of CMG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff…
NEW YORK, Dec. 12, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Zeta Global Holdings Corp. (NYSE: ZETA). Shareholders who purchased shares of ZETA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff…
NEW YORK, Dec. 12, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of ASML Holding N.V. (NASDAQ: ASML). Shareholders who purchased shares of ASML during the class period listed are encouraged to contact the firm regarding possible lead plaintiff…
NEW YORK, Dec. 12, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Hasbro, Inc. (NASDAQ: HAS). Shareholders who purchased shares of HAS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….
TAIPEI, Dec. 12, 2024 /PRNewswire/ — Advantech (2395, TW), a leading provider of AIoT platforms and services, proudly unveils its latest AI acceleration modules: the EAI-1200 and EAI-3300, powered by Hailo-8™ AI processors. These modules deliver AI performance of up to 52 TOPS while…
TAIPEI, Dec. 12, 2024 /PRNewswire/ — Advantech (2395, TW), a leading provider of AIoT platforms and services, proudly unveils its latest AI acceleration modules: the EAI-1200 and EAI-3300, powered by Hailo-8™ AI processors. These modules deliver AI performance of up to 52 TOPS while…
ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer with ESR1 mutations, aiming to delay disease progression. The study was presented by the Menarini Group and MEDSIR at the San…
ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer with ESR1 mutations, aiming to delay disease progression. The study was presented by the Menarini Group and MEDSIR at the San…
LUND, Sweden, Dec. 12, 2024 /PRNewswire/ — BPC Instruments AB (publ) (“BPC”) is pleased to announce orders from KTH Sweden and University of Texas USA, totaling 1,1 MSEK. These orders include the newly launched BPC® Air, along with BPC’s flagship product, Gas Endeavour® III. The BPC®…
